Anixter International Inc. Financial Statement Analysis
ANIXTER INTERNATIONAL INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Deferred Compensation Plan
A non-qualified deferred compensation plan was implemented on January 1, 1995. The plan permits selected employees
to make pre-tax deferrals of salary and bonus. Interest is accrued monthly on the deferred compensation balances based on the
average ten-year Treasury note rate for the previous three months times a factor of 1.4, and the rate is further adjusted if certain
financial goals are achieved. The plan provides for benefit payments upon retirement, death, disability, termination or other
scheduled dates determined by the participant. At January 3, 2020, the deferred compensation liability included in "Accrued
expenses" and "Other liabilities" on the Consolidated Balance Sheet was $3.4 million and $42.2 million, respectively. At
December 28, 2018, the deferred compensation liability included in "Accrued expenses" and "Other liabilities" on the
Consolidated Balance Sheet was $3.4 million and $42.0 million, respectively.
Concurrent with the implementation of the deferred compensation plan, the Company purchased variable, separate
account life insurance policies on the plan participants with benefits accruing to Anixter. To provide for the liabilities associated
with the deferred compensation plan and an executive non-qualified defined benefit plan, fixed general account "increasing
whole life" insurance policies were purchased on the lives of certain participants. Prior to 2006, the Company paid annual
premiums on the above company-owned policies. The last premium was paid in 2005. Policy proceeds are payable to Anixter
upon the insured participant's death. At January 3, 2020 and December 28, 2018, the cash surrender value of $41.4 million and
$37.0 million, respectively, was recorded under this program and reflected in "Other assets" on the Consolidated Balance
Sheets.
NOTE 9. STOCKHOLDERS' EQUITY
Preferred Stock
Anixter has the authority to issue 15.0 million shares of preferred stock, par value $1.00 per share, none of which were
outstanding at the end of fiscal 2019 and 2018.
Common Stock
Anixter has the authority to issue 100.0 million shares of common stock, par value $1.00 per share, of which 34.2 million
shares and 33.9 million shares were outstanding at the end of fiscal 2019 and 2018, respectively.
Share Repurchases
Anixter did not repurchase any shares during any of the periods presented in these Consolidated Financial Statements.
Stock-Based Compensation
During the second quarter of 2017, the Company's shareholders approved the 2017 Stock Incentive Plan consisting of 2.0
million shares of the Company's common stock. Prior approved stock incentive plans have been closed and will not be allowed
to issue future stock grants. At January 3, 2020, there were approximately 1.3 million shares reserved for issuance under the
2017 incentive plan.
Restricted Stock Units and Performance Units
The grant-date value of the stock units is amortized and converted to outstanding shares of common stock on a one-for-
one basis over a three, four or six-year vesting period from the date of grant based on the specific terms of the grant.
Compensation expense, net of the reversal of costs associated with forfeitures, associated with the stock units was $17.2
million, $15.7 million and $15.5 million in 2019, 2018 and 2017, respectively.
During the first quarter of 2016, Anixter initiated a performance-based restricted stock unit ("performance units")
program. For 2016, 2017 and 2018, performance units will vest in one-third tranches to be evaluated on the anniversary of the
first, second and third performance cycles. Each evaluation period will be based on the achievement of the Company's total
shareholder return ("TSR") relative to the TSR of the S&P Mid Cap 400 index. The issuance of the vested shares will be on the
final vesting date of year three. The granted units will be adjusted based on the specific payout percentage of the grant
agreement. For 2019 performance units, each evaluation period will be based on the Company's adjusted EBITDA margin for
each of the performance periods with a three year overall TSR modifier relative to the TSR of the peer group companies
determined by the Company's compensation committee calculated at the end of the three performance cycles. The fair value of
each performance unit tranche is estimated using the Monte Carlo Simulation pricing model at the date of grant.
69View entire presentation